Combinatorial therapeutic trial plans for COVID-19 treatment armed up with antiviral, antiparasitic, cell-entry inhibitor, and immune-boosters

por Roy Chattopadhyay, Nabanita, Chatterjee, Koustav, Banerjee, Antara, Choudhuri, Tathagata
Publicado 2020

TLR9 Polymorphisms Might Contribute to the Ethnicity Bias for EBV-Infected Nasopharyngeal Carcinoma

por Roy Chattopadhyay, Nabanita, Chatterjee, Koustav, Tiwari, Nikhil, Chakrabarti, Sudipta, Sahu, Sushil Kumar, Deb Roy, Sankar, Ghosh, Arijit, Reddy, R. Rajendra, Das, Piyanki, Mal, Sudipa, Karnar, Basab Bijay, Das, Ashok Kumar, Tsering, Sam, Riba, Komri, puii, Zoreng, Zomawia, Eric, Singh, Y. Indibar, Suryawanshi, Amol Ratnakar, Kumar, Abhishek, Ganguly, Dipyaman, Goswami, Chandan, Choudhuri, Tathagata
Publicado 2020